Home / JUBLPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does JUBLPHARMA.NS make money? Does JUBLPHARMA.NS have pricing power? What's the Earnings Whisper? Will JUBLPHARMA.NS profit more as the business scales? What is JUBLPHARMA.NS's management track record? Is JUBLPHARMA.NS's current price justified?

Jubilant Pharmova Limited

₹938.6 -$119.50 (-11.29%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹938.2

Day Range

₹928.6₹954.9

Year Range

₹786.05₹1184.8

Market Cap

148.66B

AVG Volume

251.63K

Trailing/Forward PE

42.2/19.19

PEG ratio

-7.54

Dividend Yield

0.53%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

JUBLPHARMA.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	86.08B
26 Q4	82.8B
26 Q3	79.18B
26 Q2	76.18B
26 Q1	74.03B
25 Q4	72.34B
25 Q3	70.64B
25 Q2	69.2B
25 Q1	68.48B
24 Q4	67.03B

Net Income (INR) · TTM

JUBLPHARMA.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	3.52B
26 Q4	3.98B
26 Q3	4.33B
26 Q2	4.78B
26 Q1	4.6B
25 Q4	8.39B
25 Q3	6.27B
25 Q2	5.93B
25 Q1	5.53B
24 Q4	771M

Operating Income (INR) · TTM

JUBLPHARMA.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	7.49B
26 Q4	13.19B
26 Q3	15.15B
26 Q2	20.33B
26 Q1	24.3B
25 Q4	23.56B
25 Q3	23.32B
25 Q2	22.04B
25 Q1	21.62B
24 Q4	20.64B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Jubilant Pharmova Limited

Video analysis: JUBLPHARMA.NS

News: JUBLPHARMA.NS

Similar companies